Andrea Giachi
Overview
Explore the profile of Andrea Giachi including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
8
Citations
13
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Gualtierotti R, Giachi A, Bitto N, La Mura V, Peyvandi F
Res Pract Thromb Haemost
. 2025 Jan;
9(1):102640.
PMID: 39810981
Hemophilia A and B are hereditary bleeding disorders associated with the X chromosome, stemming from genetic defects in the coding of coagulation factor (F)VIII or FIX protein, leading to partial...
2.
Macchi C, Giachi A, Fichtner I, Pedretti S, Sarzi-Puttini P, Sarzi Puttini P, et al.
Sci Rep
. 2024 Dec;
14(1):30247.
PMID: 39632893
Fibromyalgia is a musculoskeletal syndrome characterized by chronic widespread pain that is often associated with systemic manifestations. Since mitochondria are the main source of cellular energy, we hypothesized that fibromyalgia...
3.
Gualtierotti R, Giachi A, Suffritti C, Bedogni L, Franco F, Poggi F, et al.
Expert Rev Hematol
. 2024 Sep;
17(10):713-721.
PMID: 39245933
Introduction: The improved quality of care and increased drug availability have shifted the goal of treating people with hemophilia from life-threatening bleeding prevention to joint health preservation and quality of...
4.
Rossio R, Tettamanti M, Antonella Galbussera A, Gualtierotti R, Giachi A, Torri A, et al.
Intern Emerg Med
. 2024 May;
19(6):1577-1583.
PMID: 38761332
A systemic inflammatory response occurs during SARS-CoV2 infection and is associated with hypercoagulability and thrombotic events. From March 2020 in our hospital different dosages of low-molecular weight heparin (LMWH) were...
5.
Gualtierotti R, Giachi A, Truma A, Arcudi S, Ciavarella A, Bucciarelli P, et al.
Haemophilia
. 2024 May;
30(4):1018-1024.
PMID: 38717319
Introduction: Early diagnosis of joint damage is pivotal in haemophilia to prevent the occurrence and progression of haemophilic arthropathy thus providing optimal personalised management. The haemophilia joint health score version...
6.
Gualtierotti R, Fox S, Da Silva Lameira F, Giachi A, Valenti L, Borghi M, et al.
J Clin Med
. 2023 Jun;
12(11).
PMID: 37297922
Nailfold videocapillaroscopic alterations have been described in COVID-19, but their correlations with biomarkers of inflammation, coagulation and endothelial perturbation are still unclear, and no information is available on nailfold histopathology....
7.
Giachi A, Cugno M, Gualtierotti R
Front Cardiovasc Med
. 2022 Nov;
9:1012661.
PMID: 36352850
Rheumatoid arthritis (RA) is a chronic inflammatory disease affecting about 0. 5-1% of the adult population and manifesting as persistent synovitis, systemic inflammation and production of autoantibodies. Patients affected by...
8.
Gualtierotti R, Pasca S, Ciavarella A, Arcudi S, Giachi A, Garagiola I, et al.
Pharmaceuticals (Basel)
. 2022 Oct;
15(10).
PMID: 36297295
Over the last decade, the world of hemophilia has experienced an unprecedented therapeutic advance, thanks to the progress in bioengineering technologies, leading to the introduction of drugs with novel mechanisms...
9.
Gualtierotti R, Tafuri F, Rossio R, Rota M, Bucciarelli P, Ferrari B, et al.
J Clin Med
. 2022 Sep;
11(18).
PMID: 36143072
Hypercoagulability and endothelial dysfunction related to inflammation have been clearly demonstrated in COVID-19. However, their influence on thromboembolism, lung alterations and mortality in low-intensity-care patients with COVID-19 is not completely...